Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| RxSight, Inc.RXST · Entity 1226 | Chief Operating Officer | September 05, 2026 | September 10, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
RxSight, Inc.
Report date September 05, 2026 · Filed September 10, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $16.00 · Expires 2031-07-30 | Direct | 0 |
Reported balance
After 2026-09-05 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-09-05 · Disposition to issuer · Disposed 98,367 · Balance 0 F1: On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.33:1 basis with a post-exchange exercise price of $6.375 per share. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $14.95 · Expires 2033-03-08 | Direct | 0 |
Reported balance
After 2026-09-05 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-09-05 · Disposition to issuer · Disposed 120,000 · Balance 0 F3: On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.15:1 basis with a post-exchange exercise price of $6.375 per share. F2: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean March 9, 2023. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $56.07 · Expires 2034-03-03 | Direct | 0 |
Reported balance
After 2026-09-05 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-09-05 · Disposition to issuer · Disposed 92,200 · Balance 0 F5: On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.55:1 basis with a post-exchange exercise price of $6.375 per share. F4: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean March 4, 2024. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $46.24 · Expires 2034-08-06 | Direct | 0 |
Reported balance
After 2026-09-05 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-09-05 · Disposition to issuer · Disposed 50,000 · Balance 0 F5: On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.55:1 basis with a post-exchange exercise price of $6.375 per share. F6: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean August 7, 2024. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $28.21 · Expires 2035-02-26 | Direct | 0 |
Reported balance
After 2026-09-05 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-09-05 · Disposition to issuer · Disposed 125,000 · Balance 0 F1: On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.33:1 basis with a post-exchange exercise price of $6.375 per share. F7: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean February 27, 2025. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $6.38 · Expires 2033-09-04 | Direct | 73,960 |
Reported balance
After 2026-09-05 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-09-05 · Grant · Acquired 73,960 · Balance 73,960 F1: On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.33:1 basis with a post-exchange exercise price of $6.375 per share. F8: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, 25% of the shares subject to the option will vest on February 28, 2027 and the remaining 75% of the shares subject to the option will vest on August 31, 2027. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $6.38 · Expires 2033-09-04 | Direct | 104,347 |
Reported balance
After 2026-09-05 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-09-05 · Grant · Acquired 104,347 · Balance 104,347 F3: On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.15:1 basis with a post-exchange exercise price of $6.375 per share. F9: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, 25% of the 89,129 shares subject to the option will vest on February 28, 2027 and the remaining 75% of the 89,129 shares subject to the option will vest on August 31, 2027. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one twenty-fourth (1/24th) of the 15,218 shares subject to the option will vest on February 28, 2027 and in equal monthly installments thereafter. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $6.38 · Expires 2033-09-04 | Direct | 59,483 |
Reported balance
After 2026-09-05 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2026-09-05 · Grant · Acquired 59,483 · Balance 59,483 F5: On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.55:1 basis with a post-exchange exercise price of $6.375 per share. F10: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, 25% of the 37,177 shares subject to the option will vest on February 28, 2027 and the remaining 75% of the 37,177 shares subject to the option will vest on August 31, 2027. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one twenty-fourth (1/24th) of the 22,306 shares subject to the option will vest on February 28, 2027 and in equal monthly installments thereafter. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $6.38 · Expires 2033-09-04 | Direct | 32,258 |
Reported balance
After 2026-09-05 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2026-09-05 · Grant · Acquired 32,258 · Balance 32,258 F5: On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.55:1 basis with a post-exchange exercise price of $6.375 per share. F11: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, 25% of the 16,129 shares subject to the option will vest on February 28, 2027 and the remaining 75% of the 16,129 shares subject to the option will vest on August 31, 2027. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one twenty-fourth (1/24th) of the 16,129 shares subject to the option will vest on February 28, 2027 and in equal monthly installments thereafter. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $6.38 · Expires 2033-09-04 | Direct | 93,984 |
Reported balance
After 2026-09-05 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2026-09-05 · Grant · Acquired 93,984 · Balance 93,984 F1: On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.33:1 basis with a post-exchange exercise price of $6.375 per share. F12: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, 25% of the 35,244 shares subject to the option will vest on February 28, 2027 and the remaining 75% of the 35,244 shares subject to the option will vest on August 31, 2027. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one twenty-fourth (1/24th) of the 58,740 shares subject to the option will vest on February 28, 2027 and in equal monthly installments thereafter. |
Filing footnotes · ownership attribution and instrument terms
F1: On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.33:1 basis with a post-exchange exercise price of $6.375 per share.
F2: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean March 9, 2023.
F3: On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.15:1 basis with a post-exchange exercise price of $6.375 per share.
F4: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean March 4, 2024.
F5: On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.55:1 basis with a post-exchange exercise price of $6.375 per share.
F6: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean August 7, 2024.
F7: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean February 27, 2025.
F8: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, 25% of the shares subject to the option will vest on February 28, 2027 and the remaining 75% of the shares subject to the option will vest on August 31, 2027.
F9: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, 25% of the 89,129 shares subject to the option will vest on February 28, 2027 and the remaining 75% of the 89,129 shares subject to the option will vest on August 31, 2027. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one twenty-fourth (1/24th) of the 15,218 shares subject to the option will vest on February 28, 2027 and in equal monthly installments thereafter.
F10: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, 25% of the 37,177 shares subject to the option will vest on February 28, 2027 and the remaining 75% of the 37,177 shares subject to the option will vest on August 31, 2027. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one twenty-fourth (1/24th) of the 22,306 shares subject to the option will vest on February 28, 2027 and in equal monthly installments thereafter.
F11: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, 25% of the 16,129 shares subject to the option will vest on February 28, 2027 and the remaining 75% of the 16,129 shares subject to the option will vest on August 31, 2027. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one twenty-fourth (1/24th) of the 16,129 shares subject to the option will vest on February 28, 2027 and in equal monthly installments thereafter.
F12: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, 25% of the 35,244 shares subject to the option will vest on February 28, 2027 and the remaining 75% of the 35,244 shares subject to the option will vest on August 31, 2027. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one twenty-fourth (1/24th) of the 58,740 shares subject to the option will vest on February 28, 2027 and in equal monthly installments thereafter.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 05, 2026 Filed Sep 10, 2026 00:53 UTC | RxSight, Inc. RXST · Entity 1226 | GrantStock Option (right to buy) · Derivative | 93,984 | Not disclosed Strike: $6.38 | Not disclosed |
DisclosureSEC source: 0001193125-26-386837 · ownership.xml · derivative · entry 10 Goldshleger Ilya · CIK 0001874147 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 93,984 Underlying: Common Stock · 93,984 shares Expires 2033-09-04 F1 · price: On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.33:1 basis with a post-exchange exercise price of $6.375 per share. F12 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, 25% of the 35,244 shares subject to the option will vest on February 28, 2027 and the remaining 75% of the 35,244 shares subject to the option will vest on August 31, 2027. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one twenty-fourth (1/24th) of the 58,740 shares subject to the option will vest on February 28, 2027 and in equal monthly installments thereafter. Read SEC document |
| September 05, 2026 Filed Sep 10, 2026 00:53 UTC | RxSight, Inc. RXST · Entity 1226 | GrantStock Option (right to buy) · Derivative | 32,258 | Not disclosed Strike: $6.38 | Not disclosed |
DisclosureSEC source: 0001193125-26-386837 · ownership.xml · derivative · entry 9 Goldshleger Ilya · CIK 0001874147 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,258 Underlying: Common Stock · 32,258 shares Expires 2033-09-04 F5 · price: On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.55:1 basis with a post-exchange exercise price of $6.375 per share. F11 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, 25% of the 16,129 shares subject to the option will vest on February 28, 2027 and the remaining 75% of the 16,129 shares subject to the option will vest on August 31, 2027. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one twenty-fourth (1/24th) of the 16,129 shares subject to the option will vest on February 28, 2027 and in equal monthly installments thereafter. Read SEC document |
| September 05, 2026 Filed Sep 10, 2026 00:53 UTC | RxSight, Inc. RXST · Entity 1226 | GrantStock Option (right to buy) · Derivative | 59,483 | Not disclosed Strike: $6.38 | Not disclosed |
DisclosureSEC source: 0001193125-26-386837 · ownership.xml · derivative · entry 8 Goldshleger Ilya · CIK 0001874147 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,483 Underlying: Common Stock · 59,483 shares Expires 2033-09-04 F5 · price: On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.55:1 basis with a post-exchange exercise price of $6.375 per share. F10 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, 25% of the 37,177 shares subject to the option will vest on February 28, 2027 and the remaining 75% of the 37,177 shares subject to the option will vest on August 31, 2027. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one twenty-fourth (1/24th) of the 22,306 shares subject to the option will vest on February 28, 2027 and in equal monthly installments thereafter. Read SEC document |
| September 05, 2026 Filed Sep 10, 2026 00:53 UTC | RxSight, Inc. RXST · Entity 1226 | GrantStock Option (right to buy) · Derivative | 104,347 | Not disclosed Strike: $6.38 | Not disclosed |
DisclosureSEC source: 0001193125-26-386837 · ownership.xml · derivative · entry 7 Goldshleger Ilya · CIK 0001874147 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 104,347 Underlying: Common Stock · 104,347 shares Expires 2033-09-04 F3 · price: On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.15:1 basis with a post-exchange exercise price of $6.375 per share. F9 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, 25% of the 89,129 shares subject to the option will vest on February 28, 2027 and the remaining 75% of the 89,129 shares subject to the option will vest on August 31, 2027. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one twenty-fourth (1/24th) of the 15,218 shares subject to the option will vest on February 28, 2027 and in equal monthly installments thereafter. Read SEC document |
| September 05, 2026 Filed Sep 10, 2026 00:53 UTC | RxSight, Inc. RXST · Entity 1226 | GrantStock Option (right to buy) · Derivative | 73,960 | Not disclosed Strike: $6.38 | Not disclosed |
DisclosureSEC source: 0001193125-26-386837 · ownership.xml · derivative · entry 6 Goldshleger Ilya · CIK 0001874147 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,960 Underlying: Common Stock · 73,960 shares Expires 2033-09-04 F1 · price: On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.33:1 basis with a post-exchange exercise price of $6.375 per share. F8 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, 25% of the shares subject to the option will vest on February 28, 2027 and the remaining 75% of the shares subject to the option will vest on August 31, 2027. Read SEC document |
| September 05, 2026 Filed Sep 10, 2026 00:53 UTC | RxSight, Inc. RXST · Entity 1226 | Disposition to issuerStock Option (right to buy) · Derivative | 125,000 | Not disclosed Strike: $28.21 | Not disclosed |
DisclosureSEC source: 0001193125-26-386837 · ownership.xml · derivative · entry 5 Goldshleger Ilya · CIK 0001874147 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 125,000 shares Expires 2035-02-26 F1 · price: On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.33:1 basis with a post-exchange exercise price of $6.375 per share. F7 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean February 27, 2025. Read SEC document |
| September 05, 2026 Filed Sep 10, 2026 00:53 UTC | RxSight, Inc. RXST · Entity 1226 | Disposition to issuerStock Option (right to buy) · Derivative | 50,000 | Not disclosed Strike: $46.24 | Not disclosed |
DisclosureSEC source: 0001193125-26-386837 · ownership.xml · derivative · entry 4 Goldshleger Ilya · CIK 0001874147 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 50,000 shares Expires 2034-08-06 F5 · price: On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.55:1 basis with a post-exchange exercise price of $6.375 per share. F6 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean August 7, 2024. Read SEC document |
| September 05, 2026 Filed Sep 10, 2026 00:53 UTC | RxSight, Inc. RXST · Entity 1226 | Disposition to issuerStock Option (right to buy) · Derivative | 92,200 | Not disclosed Strike: $56.07 | Not disclosed |
DisclosureSEC source: 0001193125-26-386837 · ownership.xml · derivative · entry 3 Goldshleger Ilya · CIK 0001874147 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 92,200 shares Expires 2034-03-03 F5 · price: On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.55:1 basis with a post-exchange exercise price of $6.375 per share. F4 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean March 4, 2024. Read SEC document |
| September 05, 2026 Filed Sep 10, 2026 00:53 UTC | RxSight, Inc. RXST · Entity 1226 | Disposition to issuerStock Option (right to buy) · Derivative | 120,000 | Not disclosed Strike: $14.95 | Not disclosed |
DisclosureSEC source: 0001193125-26-386837 · ownership.xml · derivative · entry 2 Goldshleger Ilya · CIK 0001874147 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 120,000 shares Expires 2033-03-08 F3 · price: On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.15:1 basis with a post-exchange exercise price of $6.375 per share. F2 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean March 9, 2023. Read SEC document |
| September 05, 2026 Filed Sep 10, 2026 00:53 UTC | RxSight, Inc. RXST · Entity 1226 | Disposition to issuerStock option (right to buy) · Derivative | 98,367 | Not disclosed Strike: $16.00 | Not disclosed |
DisclosureSEC source: 0001193125-26-386837 · ownership.xml · derivative · entry 1 Goldshleger Ilya · CIK 0001874147 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 98,367 shares Expires 2031-07-30 F1 · price: On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.33:1 basis with a post-exchange exercise price of $6.375 per share. Read SEC document |
| September 02, 2026 Filed Sep 3, 2026 01:34 UTC | RxSight, Inc. RXST · Entity 1226 | SaleCommon Stock | 2,041 | $6.96 | $14,205.36 |
DisclosureSEC source: 0001193125-26-380711 · ownership.xml · nonDerivative · entry 2 Goldshleger Ilya · CIK 0001874147 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,509 F2 · kind: Represents the number of shares sold to cover the tax withholding obligations in connection with the vesting of RSUs and does not represent a discretionary sale by the Reporting Person. Read SEC document |
| August 31, 2026 Filed Sep 3, 2026 01:34 UTC | RxSight, Inc. RXST · Entity 1226 | Exercise / conversionRestricted Stock Unit · Derivative | 5,370 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-380711 · ownership.xml · derivative · entry 4 Goldshleger Ilya · CIK 0001874147 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,848 Underlying: Common Stock · 5,370 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F3 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan (the "Plan")) through each applicable date, one-sixth (1/6th) of the RSUs subject to the award shall vest on the first Trading Day (as defined in the Plan) on or after each of August 31, 2026, February 28, 2027, August 31, 2027, February 28, 2028, August 31, 2028 and February 28, 2029. F3 · derivative.expiration_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan (the "Plan")) through each applicable date, one-sixth (1/6th) of the RSUs subject to the award shall vest on the first Trading Day (as defined in the Plan) on or after each of August 31, 2026, February 28, 2027, August 31, 2027, February 28, 2028, August 31, 2028 and February 28, 2029. Read SEC document |
| August 31, 2026 Filed Sep 3, 2026 01:34 UTC | RxSight, Inc. RXST · Entity 1226 | Exercise / conversionCommon Stock | 5,370 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-380711 · ownership.xml · nonDerivative · entry 1 Goldshleger Ilya · CIK 0001874147 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,550 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| April 17, 2026 Filed Apr 20, 2026 20:19 UTC | RxSight, Inc. RXST · Entity 1226 | Exercise / conversionStock Option (right to buy) · Derivative | 12,489 | $0.00 Strike: $4.13 | $0.00 |
DisclosureSEC source: 0001193125-26-164041 · ownership.xml · derivative · entry 3 Goldshleger Ilya · CIK 0001874147 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5 Underlying: Common Stock · 12,489 shares Expires 2027-04-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 17, 2026 Filed Apr 20, 2026 20:19 UTC | RxSight, Inc. RXST · Entity 1226 | Exercise / conversionCommon Stock | 12,489 | $4.13 | $51,579.57 |
DisclosureSEC source: 0001193125-26-164041 · ownership.xml · nonDerivative · entry 1 Goldshleger Ilya · CIK 0001874147 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,180 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 27, 2026 Filed Mar 4, 2026 01:21 UTC | RxSight, Inc. RXST · Entity 1226 | GrantRestricted Stock Unit · Derivative | 32,218 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-089493 · ownership.xml · derivative · entry 1 Goldshleger Ilya · CIK 0001874147 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,218 Underlying: Common Stock · 32,218 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F2 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan (the "Plan")) through each applicable date, one-sixth (1/6th) of the RSUs subject to the award shall vest on the first Trading Day (as defined in the Plan) on or after each of August 31, 2026, February 28, 2027, August 31, 2027, February 28, 2028, August 31, 2028 and February 28, 2029. F2 · derivative.expiration_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan (the "Plan")) through each applicable date, one-sixth (1/6th) of the RSUs subject to the award shall vest on the first Trading Day (as defined in the Plan) on or after each of August 31, 2026, February 28, 2027, August 31, 2027, February 28, 2028, August 31, 2028 and February 28, 2029. Read SEC document |
| September 25, 2025 Filed Sep 26, 2025 20:07 UTC | RxSight, Inc. RXST · Entity 1226 | Exercise / conversionStock Option (right to buy) · Derivative | 8,349 | $0.00 Strike: $4.13 | $0.00 |
DisclosureSEC source: 0001193125-25-220465 · ownership.xml · derivative · entry 6 Goldshleger Ilya · CIK 0001874147 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,494 Underlying: Common Stock · 8,349 shares Expires 2027-04-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 25, 2025 Filed Sep 26, 2025 20:07 UTC | RxSight, Inc. RXST · Entity 1226 | Exercise / conversionStock Option (right to buy) · Derivative | 9,680 | $0.00 Strike: $4.34 | $0.00 |
DisclosureSEC source: 0001193125-25-220465 · ownership.xml · derivative · entry 5 Goldshleger Ilya · CIK 0001874147 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,680 shares Expires 2027-03-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 25, 2025 Filed Sep 26, 2025 20:07 UTC | RxSight, Inc. RXST · Entity 1226 | Exercise / conversionStock Option (right to buy) · Derivative | 5,416 | $0.00 Strike: $4.34 | $0.00 |
DisclosureSEC source: 0001193125-25-220465 · ownership.xml · derivative · entry 4 Goldshleger Ilya · CIK 0001874147 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,416 shares Expires 2026-10-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 25, 2025 Filed Sep 26, 2025 20:07 UTC | RxSight, Inc. RXST · Entity 1226 | Exercise / conversionCommon Stock | 8,349 | $4.13 | $34,481.37 |
DisclosureSEC source: 0001193125-25-220465 · ownership.xml · nonDerivative · entry 2 Goldshleger Ilya · CIK 0001874147 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,691 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 25, 2025 Filed Sep 26, 2025 20:07 UTC | RxSight, Inc. RXST · Entity 1226 | Exercise / conversionCommon Stock | 15,096 | $4.34 | $65,516.64 |
DisclosureSEC source: 0001193125-25-220465 · ownership.xml · nonDerivative · entry 1 Goldshleger Ilya · CIK 0001874147 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,342 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 27, 2025 Filed Feb 28, 2025 01:05 UTC | RxSight, Inc. RXST · Entity 1226 | GrantStock Option (right to buy) · Derivative | 125,000 | $0.00 Strike: $28.21 | $0.00 |
DisclosureSEC source: 0000950170-25-029397 · ownership.xml · derivative · entry 1 Goldshleger Ilya · CIK 0001874147 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires 2035-02-26 F1 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean February 27, 2025. Read SEC document |
| November 29, 2024 Filed Dec 3, 2024 23:38 UTC | RxSight, Inc. RXST · Entity 1226 | Exercise / conversionStock Option (right to buy) · Derivative | 3,105 | $0.00 Strike: $15.08 | $0.00 |
DisclosureSEC source: 0000950170-24-132976 · ownership.xml · derivative · entry 4 Goldshleger Ilya · CIK 0001874147 · See remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 40,777 Underlying: Common Stock · 3,105 shares Expires 2030-04-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2015 Equity Incentive Plan, as amended) through each applicable date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean April 23, 2020. Read SEC document |
| November 29, 2024 Filed Dec 3, 2024 23:38 UTC | RxSight, Inc. RXST · Entity 1226 | SaleCommon Stock | 3,105 | $46.08 | $143,078.40 |
DisclosureSEC source: 0000950170-24-132976 · ownership.xml · nonDerivative · entry 2 Goldshleger Ilya · CIK 0001874147 · See remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 42,246 F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted on June 3, 2024 by the Reporting Person. Read SEC document |
| November 29, 2024 Filed Dec 3, 2024 23:38 UTC | RxSight, Inc. RXST · Entity 1226 | Exercise / conversionCommon Stock | 3,105 | $15.08 | $46,823.40 |
DisclosureSEC source: 0000950170-24-132976 · ownership.xml · nonDerivative · entry 1 Goldshleger Ilya · CIK 0001874147 · See remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 45,351 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 26, 2024 Filed Nov 27, 2024 00:25 UTC | RxSight, Inc. RXST · Entity 1226 | Exercise / conversionStock Option (right to buy) · Derivative | 3,100 | $0.00 Strike: $15.08 | $0.00 |
DisclosureSEC source: 0000950170-24-131200 · ownership.xml · derivative · entry 7 Goldshleger Ilya · CIK 0001874147 · See remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,882 Underlying: Common Stock · 3,100 shares Expires 2030-04-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2015 Equity Incentive Plan, as amended) through each applicable date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean April 23, 2020. Read SEC document |
| November 26, 2024 Filed Nov 27, 2024 00:25 UTC | RxSight, Inc. RXST · Entity 1226 | SaleCommon Stock | 3,100 | $45.88 | $142,228.00 |
DisclosureSEC source: 0000950170-24-131200 · ownership.xml · nonDerivative · entry 4 Goldshleger Ilya · CIK 0001874147 · See remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 42,246 F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted on June 3, 2024 by the Reporting Person. Read SEC document |
| November 26, 2024 Filed Nov 27, 2024 00:25 UTC | RxSight, Inc. RXST · Entity 1226 | Exercise / conversionCommon Stock | 3,100 | $15.08 | $46,748.00 |
DisclosureSEC source: 0000950170-24-131200 · ownership.xml · nonDerivative · entry 3 Goldshleger Ilya · CIK 0001874147 · See remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 45,346 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 22, 2024 Filed Nov 27, 2024 00:25 UTC | RxSight, Inc. RXST · Entity 1226 | Exercise / conversionStock Option (right to buy) · Derivative | 3,100 | $0.00 Strike: $15.08 | $0.00 |
DisclosureSEC source: 0000950170-24-131200 · ownership.xml · derivative · entry 6 Goldshleger Ilya · CIK 0001874147 · See remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 46,982 Underlying: Common Stock · 3,100 shares Expires 2030-04-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2015 Equity Incentive Plan, as amended) through each applicable date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean April 23, 2020. Read SEC document |
| November 22, 2024 Filed Nov 27, 2024 00:25 UTC | RxSight, Inc. RXST · Entity 1226 | SaleCommon Stock | 3,100 | $45.00 | $139,500.00 |
DisclosureSEC source: 0000950170-24-131200 · ownership.xml · nonDerivative · entry 2 Goldshleger Ilya · CIK 0001874147 · See remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 42,246 F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted on June 3, 2024 by the Reporting Person. Read SEC document |
| November 22, 2024 Filed Nov 27, 2024 00:25 UTC | RxSight, Inc. RXST · Entity 1226 | Exercise / conversionCommon Stock | 3,100 | $15.08 | $46,748.00 |
DisclosureSEC source: 0000950170-24-131200 · ownership.xml · nonDerivative · entry 1 Goldshleger Ilya · CIK 0001874147 · See remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 45,346 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 18, 2024 Filed Nov 19, 2024 02:50 UTC | RxSight, Inc. RXST · Entity 1226 | Exercise / conversionStock Option (right to buy) · Derivative | 3,100 | $0.00 Strike: $15.08 | $0.00 |
DisclosureSEC source: 0000950170-24-128218 · ownership.xml · derivative · entry 8 Goldshleger Ilya · CIK 0001874147 · See remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 50,082 Underlying: Common Stock · 3,100 shares Expires 2030-04-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2015 Equity Incentive Plan, as amended) through each applicable date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean April 23, 2020. Read SEC document |
| November 18, 2024 Filed Nov 19, 2024 02:50 UTC | RxSight, Inc. RXST · Entity 1226 | SaleCommon Stock | 33 | $45.07 | $1,487.31 |
DisclosureSEC source: 0000950170-24-128218 · ownership.xml · nonDerivative · entry 5 Goldshleger Ilya · CIK 0001874147 · See remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 42,246 F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted on June 3, 2024 by the Reporting Person. Read SEC document |
| November 18, 2024 Filed Nov 19, 2024 02:50 UTC | RxSight, Inc. RXST · Entity 1226 | SaleCommon Stock | 3,067 | $45.00 | $138,015.00 |
DisclosureSEC source: 0000950170-24-128218 · ownership.xml · nonDerivative · entry 4 Goldshleger Ilya · CIK 0001874147 · See remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 42,279 F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted on June 3, 2024 by the Reporting Person. Read SEC document |
| November 18, 2024 Filed Nov 19, 2024 02:50 UTC | RxSight, Inc. RXST · Entity 1226 | Exercise / conversionCommon Stock | 3,100 | $15.08 | $46,748.00 |
DisclosureSEC source: 0000950170-24-128218 · ownership.xml · nonDerivative · entry 3 Goldshleger Ilya · CIK 0001874147 · See remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 45,346 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 15, 2024 Filed Nov 19, 2024 02:50 UTC | RxSight, Inc. RXST · Entity 1226 | Exercise / conversionStock Option (right to buy) · Derivative | 4,875 | $0.00 Strike: $15.08 | $0.00 |
DisclosureSEC source: 0000950170-24-128218 · ownership.xml · derivative · entry 7 Goldshleger Ilya · CIK 0001874147 · See remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 53,182 Underlying: Common Stock · 4,875 shares Expires 2030-04-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2015 Equity Incentive Plan, as amended) through each applicable date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean April 23, 2020. Read SEC document |
| November 15, 2024 Filed Nov 19, 2024 02:50 UTC | RxSight, Inc. RXST · Entity 1226 | SaleCommon Stock | 4,875 | $46.00 | $224,250.00 |
DisclosureSEC source: 0000950170-24-128218 · ownership.xml · nonDerivative · entry 2 Goldshleger Ilya · CIK 0001874147 · See remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 42,246 F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted on June 3, 2024 by the Reporting Person. Read SEC document |
| November 15, 2024 Filed Nov 19, 2024 02:50 UTC | RxSight, Inc. RXST · Entity 1226 | Exercise / conversionCommon Stock | 4,875 | $15.08 | $73,515.00 |
DisclosureSEC source: 0000950170-24-128218 · ownership.xml · nonDerivative · entry 1 Goldshleger Ilya · CIK 0001874147 · See remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 47,121 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 12, 2024 Filed Nov 15, 2024 00:42 UTC | RxSight, Inc. RXST · Entity 1226 | Exercise / conversionStock Option (right to buy) · Derivative | 1,330 | $0.00 Strike: $15.08 | $0.00 |
DisclosureSEC source: 0000950170-24-127346 · ownership.xml · derivative · entry 4 Goldshleger Ilya · CIK 0001874147 · See remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 58,057 Underlying: Common Stock · 1,330 shares Expires 2030-04-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2015 Equity Incentive Plan, as amended) through each applicable date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean April 23, 2020. Read SEC document |
| November 12, 2024 Filed Nov 15, 2024 00:42 UTC | RxSight, Inc. RXST · Entity 1226 | SaleCommon Stock | 1,330 | $46.13 | $61,356.23 |
DisclosureSEC source: 0000950170-24-127346 · ownership.xml · nonDerivative · entry 2 Goldshleger Ilya · CIK 0001874147 · See remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 42,246 F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted on June 3, 2024 by the Reporting Person. F2 · price: Represents the weighted average share price of an aggregate total of 1,330 shares sold in the price range of $46.00 to $46.32 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| November 12, 2024 Filed Nov 15, 2024 00:42 UTC | RxSight, Inc. RXST · Entity 1226 | Exercise / conversionCommon Stock | 1,330 | $15.08 | $20,056.40 |
DisclosureSEC source: 0000950170-24-127346 · ownership.xml · nonDerivative · entry 1 Goldshleger Ilya · CIK 0001874147 · See remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,576 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 07, 2024 Filed Nov 8, 2024 21:00 UTC | RxSight, Inc. RXST · Entity 1226 | Exercise / conversionStock Option (right to buy) · Derivative | 3,100 | $0.00 Strike: $15.08 | $0.00 |
DisclosureSEC source: 0000950170-24-124035 · ownership.xml · derivative · entry 5 Goldshleger Ilya · CIK 0001874147 · See remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 59,387 Underlying: Common Stock · 3,100 shares Expires 2030-04-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2015 Equity Incentive Plan, as amended) through each applicable date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean April 23, 2020. Read SEC document |
| November 07, 2024 Filed Nov 8, 2024 21:00 UTC | RxSight, Inc. RXST · Entity 1226 | SaleCommon Stock | 200 | $55.53 | $11,106.00 |
DisclosureSEC source: 0000950170-24-124035 · ownership.xml · nonDerivative · entry 3 Goldshleger Ilya · CIK 0001874147 · See remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 42,246 F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted on June 3, 2024 by the Reporting Person. Read SEC document |
| November 07, 2024 Filed Nov 8, 2024 21:00 UTC | RxSight, Inc. RXST · Entity 1226 | SaleCommon Stock | 2,900 | $54.96 | $159,388.64 |
DisclosureSEC source: 0000950170-24-124035 · ownership.xml · nonDerivative · entry 2 Goldshleger Ilya · CIK 0001874147 · See remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 42,446 F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted on June 3, 2024 by the Reporting Person. F2 · price: Represents the weighted average share price of an aggregate total of 2,900 shares sold in the price range of $54.41 to $55.26 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| November 07, 2024 Filed Nov 8, 2024 21:00 UTC | RxSight, Inc. RXST · Entity 1226 | Exercise / conversionCommon Stock | 3,100 | $15.08 | $46,748.00 |
DisclosureSEC source: 0000950170-24-124035 · ownership.xml · nonDerivative · entry 1 Goldshleger Ilya · CIK 0001874147 · See remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 45,346 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 04, 2024 Filed Nov 5, 2024 21:05 UTC | RxSight, Inc. RXST · Entity 1226 | Exercise / conversionStock Option (right to buy) · Derivative | 3,100 | $0.00 Strike: $15.08 | $0.00 |
DisclosureSEC source: 0000950170-24-121454 · ownership.xml · derivative · entry 5 Goldshleger Ilya · CIK 0001874147 · See remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 62,487 Underlying: Common Stock · 3,100 shares Expires 2030-04-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2015 Equity Incentive Plan, as amended) through each applicable date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean April 23, 2020. Read SEC document |
| November 04, 2024 Filed Nov 5, 2024 21:05 UTC | RxSight, Inc. RXST · Entity 1226 | SaleCommon Stock | 260 | $51.74 | $13,451.67 |
DisclosureSEC source: 0000950170-24-121454 · ownership.xml · nonDerivative · entry 3 Goldshleger Ilya · CIK 0001874147 · See remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 42,246 F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted on June 3, 2024 by the Reporting Person. F3 · price: Represents the weighted average share price of an aggregate total of 260 shares sold in the price range of $51.68 to $51.805 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| November 04, 2024 Filed Nov 5, 2024 21:05 UTC | RxSight, Inc. RXST · Entity 1226 | SaleCommon Stock | 2,840 | $50.98 | $144,795.41 |
DisclosureSEC source: 0000950170-24-121454 · ownership.xml · nonDerivative · entry 2 Goldshleger Ilya · CIK 0001874147 · See remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 42,506 F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted on June 3, 2024 by the Reporting Person. F2 · price: Represents the weighted average share price of an aggregate total of 2,840 shares sold in the price range of $50.67 to $51.435 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| November 04, 2024 Filed Nov 5, 2024 21:05 UTC | RxSight, Inc. RXST · Entity 1226 | Exercise / conversionCommon Stock | 3,100 | $15.08 | $46,748.00 |
DisclosureSEC source: 0000950170-24-121454 · ownership.xml · nonDerivative · entry 1 Goldshleger Ilya · CIK 0001874147 · See remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 45,346 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 30, 2024 Filed Oct 31, 2024 21:22 UTC | RxSight, Inc. RXST · Entity 1226 | Exercise / conversionStock Option (right to buy) · Derivative | 3,105 | $0.00 Strike: $15.08 | $0.00 |
DisclosureSEC source: 0000950170-24-119658 · ownership.xml · derivative · entry 4 Goldshleger Ilya · CIK 0001874147 · See remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 65,587 Underlying: Common Stock · 3,105 shares Expires 2030-04-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2015 Equity Incentive Plan, as amended) through each applicable date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean April 23, 2020. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.